Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Cerium Phosphate Nanoparticles: Synthesis, Characterization, Biocompatibility, Regenerative Potential, and Antioxidant Activity

Silina EV., Stupin VA., Manturova NE., Chuvilina EL., Gasanov AA., Andreeva OI.

Laboratory Study on Chronic Wound, published in Molecules (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Molecules (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41097336
PMCID
PMC12525837
DOI
10.3390/molecules30193916

Abstract (original English)

The aim of this study was to synthesize, characterize, and investigate the biomedical effects of nanoscale cerium phosphate obtained via different synthesis techniques, as well as to evaluate the influence of various CePO 4 concentrations on cells involved in skin structure regeneration (human mesenchymal stem cells, keratinocytes, and fibroblasts) and establish their antioxidant properties. Methods and Results: Cerium(III) orthophosphate was obtained by precipitation with ammonium dihydrogen phosphate from a nitrate solution. By changing the initial concentrations of the solutions and the drying and annealing temperatures, the best conditions for obtaining nanosized phosphate powders were established. The structure of rhabdophane was obtained by X-ray diffraction analysis, and the particle sizes were measured by transmission electron microscopy. The particle sizes ranged from 2 to 10 nm in the transverse direction and 20 to 50 nm in the longitudinal direction. Studies on cell lines have shown a high level of safety, as well as the regenerative potential of CePO 4 nanoparticles, which have a stimulating effect on the proliferation of MSCs at concentrations of 10 -2 to 10 -3 M for 48 h after application and stimulate the metabolism of human keratinocytes and fibroblasts at a wide range of concentrations (10 -3 to 10 -5 M). A dose-dependent antioxidant effect of small CePO 4 nano

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cell LineFibroblastsKeratinocytesMesenchymal Stem CellsHumansPhosphatesCeriumBiocompatible MaterialsAntioxidantsRegeneration

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research